These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2272092)

  • 21. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study.
    Diener HC; Krupp P; Schmitt T; Steitz G; Milde K; Freytag S
    Cephalalgia; 2001 Feb; 21(1):66-70. PubMed ID: 11298666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propranolol in the treatment of migraine.
    Behan PO; Reid M
    Practitioner; 1980 Feb; 224(1340):201-3. PubMed ID: 6988825
    [No Abstract]   [Full Text] [Related]  

  • 23. Propranolol in the treatment of migraine.
    Wideroe TE; Vigander T
    Br Med J; 1974 Jun; 2(5921):699-701. PubMed ID: 4604977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Ups J Med Sci Suppl; 1980; 31():37-40. PubMed ID: 7006182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F; Shaygannejad V; Akbari M
    Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Propranolol Prophylaxis on Headache Frequency in Children with Migraine Without Aura: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Keerthana D; Mishra D; Chauhan MK; Juneja M
    Indian J Pediatr; 2023 Sep; 90(9):880-885. PubMed ID: 35867273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
    Johnson RH; Hornabrook RW; Lambie DG
    Acta Neurol Scand; 1986 May; 73(5):490-2. PubMed ID: 3524092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial.
    Ashrafi MR; Salehi S; Malamiri RA; Heidari M; Hosseini SA; Samiei M; Tavasoli AR; Togha M
    Pediatr Neurol; 2014 Oct; 51(4):503-8. PubMed ID: 25023977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
    Diener HC; Matias-Guiu J; Hartung E; Pfaffenrath V; Ludin HP; Nappi G; De Beukelaar F
    Cephalalgia; 2002 Apr; 22(3):209-21. PubMed ID: 12047461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A; Serratrice G; Collard M; Hirsch E; Feve J; Masson M; Masson C; Dry J; Koulikovsky G; Nguyen G
    Therapie; 1990; 45(5):441-5. PubMed ID: 2260046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study.
    Andersson PG; Petersen EN
    Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study.
    Pradalier A; Serratrice G; Collard M; Hirsch E; Feve J; Masson M; Masson C; Dry J; Koulikovsky G; Nguyen G
    Cephalalgia; 1989 Dec; 9(4):247-53. PubMed ID: 2692838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function.
    Edwards KR; Rosenthal BL; Farmer KU; Cady RK; Browning R
    Headache; 2013 Apr; 53(4):656-64. PubMed ID: 23406052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial.
    Kåss B; Nestvold K
    Acta Neurol Scand; 1980 Jun; 61(6):351-6. PubMed ID: 6998250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM; Schultz LL; Gilkey SJ
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sumatriptan in the treatment of acute migraine with aura.
    Banerjee M; Findley LJ
    Cephalalgia; 1992 Feb; 12(1):39-44. PubMed ID: 1313746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset of action of various migraine prophylactics.
    Amery WK
    Cephalalgia; 1988; 8 Suppl 8():11-3. PubMed ID: 3180197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.